Cargando…
Virological cure, clinical efficacy and safety of Remdesivir supplementation against SARS-CoV 2 infection; evidence from human studies
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Masson SAS.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7538068/ http://dx.doi.org/10.1016/j.phclin.2020.08.007 |
| _version_ | 1783590792531542016 |
|---|---|
| author | Ghazvini, K. Keikha, M. |
| author_facet | Ghazvini, K. Keikha, M. |
| author_sort | Ghazvini, K. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7538068 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier Masson SAS. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-75380682020-10-07 Virological cure, clinical efficacy and safety of Remdesivir supplementation against SARS-CoV 2 infection; evidence from human studies Ghazvini, K. Keikha, M. Le Pharmacien Hospitalier & Clinicien Letter to the Editor Elsevier Masson SAS. 2021-03 2020-10-06 /pmc/articles/PMC7538068/ http://dx.doi.org/10.1016/j.phclin.2020.08.007 Text en © 2020 Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Ghazvini, K. Keikha, M. Virological cure, clinical efficacy and safety of Remdesivir supplementation against SARS-CoV 2 infection; evidence from human studies |
| title | Virological cure, clinical efficacy and safety of Remdesivir supplementation against SARS-CoV 2 infection; evidence from human studies |
| title_full | Virological cure, clinical efficacy and safety of Remdesivir supplementation against SARS-CoV 2 infection; evidence from human studies |
| title_fullStr | Virological cure, clinical efficacy and safety of Remdesivir supplementation against SARS-CoV 2 infection; evidence from human studies |
| title_full_unstemmed | Virological cure, clinical efficacy and safety of Remdesivir supplementation against SARS-CoV 2 infection; evidence from human studies |
| title_short | Virological cure, clinical efficacy and safety of Remdesivir supplementation against SARS-CoV 2 infection; evidence from human studies |
| title_sort | virological cure, clinical efficacy and safety of remdesivir supplementation against sars-cov 2 infection; evidence from human studies |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7538068/ http://dx.doi.org/10.1016/j.phclin.2020.08.007 |
| work_keys_str_mv | AT ghazvinik virologicalcureclinicalefficacyandsafetyofremdesivirsupplementationagainstsarscov2infectionevidencefromhumanstudies AT keikham virologicalcureclinicalefficacyandsafetyofremdesivirsupplementationagainstsarscov2infectionevidencefromhumanstudies |